[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335829-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335829-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","diffusion-mri-in-prostate-cancer-with-ultra-strong-whole-body-gradients-read-online-free","Diffusion MRI in prostate cancer with ultra-strong whole-body gradients - read online free","","Diffusion-weighted MRI (dMRI) is widely recommended for detecting and classifying prostate cancer (PCa), using PI-RADS guidance to acquire sufficiently high b-values. Clinical dMRI is limited by low signal-to-noise ratio caused by prolonged echo times from limited gradient power (40–80 mT/m). This study evaluates feasibility and image quality in PCa using a 300 mT/m whole-body system, comparing high b-value acquisitions, artefacts and their correction, and quantifying SNR and contrast-to-noise ratio improvements across protocols for diagnostic radiology scoring.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/diffusion-mri-in-prostate-cancer-with-ultra-strong-whole-body-gradients-read-online-free/335829/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/diffusion-mri-in-prostate-cancer-with-ultra-strong-whole-body-gradients-read-online-free/335829.png","ImageObject",300,407,{"name":42,"@type":43},"Ophelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is diffusion-weighted MRI challenging in clinical prostate cancer imaging?","Question",{"text":63,"@type":64},"Clinical dMRI often has low signal-to-noise ratio due to prolonged echo times caused by limited gradient power, which increases signal loss from transverse relaxation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What was the goal of using a 300 mT/m whole-body diffusion MRI system?",{"text":68,"@type":64},"The study aimed to assess feasibility and improve data quality, SNR, and contrast-to-noise ratio for prostate cancer measurements using ultra-strong gradients.",{"name":70,"@type":61,"acceptedAnswer":71},"How did strong gradients affect image quality and contrast in the study?",{"text":72,"@type":64},"Strong gradients enabled a significant SNR gain per unit time and a 1.6–2.1-fold increase in contrast-to-noise ratio, while artefact correction supported acceptable diagnostic outcomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335829,1790098768,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":30,"preview_urls":145},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Europe PMC unders uthManuscripts Europe M eC und Author Manuscripts  \n| Europe PMC Funders Group\u003Cbr>Author Manuscript\u003Cbr>NMR Biomed. Author manuscript; available in PMC 2025 March 13. |\n| --- |\n| Published in final edited form as:\u003Cbr>NMR Biomed. 2024 December 01; 37(12): e5229 . doi:10.1002/nbm.5229 .\u003Cbr>Diffusion MRI in prostate cancer with ultra-strong whole-body gradients\u003Cbr>Malwina Molendowska 1 , Marco Palombo 1,2 , Kieran G. Foley3 , Krishna Narahari4 , Fabrizio Fasano5,6 , Derek K. Jones 1 , Daniel C. Alexander7 , Eleftheria Panagiotaki7 , Chantal M.W. Tax 1,8\u003Cbr>1Cardiff University Brain Research Imaging Centre (CUBRIC), Cardiff University, Cardiff, UK.\u003Cbr>2School of Computer Science and Informatics, Cardiff University, Cardiff, UK.\u003Cbr>3 Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.\u003Cbr>4Cardiff and Vale University Health Board, Heath Park Campus, , Cardiff, UK.\u003Cbr>5Siemens Healthcare Ltd, Camberley, UK\u003Cbr>6Siemens Healthcare GmbH, Erlangen, Germany.\u003Cbr>7Centre for Medical Image Computing, University College London, London, UK.\u003Cbr>8 Image Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands.\u003Cbr>Abstract\u003Cbr>Diffusion-weighted MRI (dMRI) is universally recommended for the detection and classification of prostate cancer (PCa), with PI-RADS recommendations to acquire b-values of ≥1 .4 ms/μm2.\u003Cbr>However, clinical dMRI suffers from a low signal-to-noise ratio (SNR) as the consequence of prolonged echo times (TEs) attributable to the limited gradient power in the range of 40−80 mT/m. To overcome this, MRI systems with strong gradients have been designed but so far have mainly been applied in the brain. The aim of this work was to assess the feasibility, data quality, SNR and contrast-to-noise ratio (CNR) of measurements in PCa with a 300 mT/m whole-body system. A cohort of men without and with diagnosed PCa were imaged on a research-only 3T Connectom Siemens MRI system equipped with a gradient amplitude of 300 mT/m. dMRI at high b-values were acquired using high gradient amplitudes and compared with gradient capabilities mimicking clinical systems. Data artefacts typically amplified with stronger gradients were assessed and their correction evaluated. The SNR gains and lesion-to-healthy tissue CNR were statistically tested investigating the effect of protocol and b-value. The diagnostic quality of the images for different dMRI protocols was assessed by an experienced radiologist using a 5-point Likert scale and an adapted PI-QUAL scoring system. The strong gradients for prostate dMRI allowed a significant gain in SNR per unit time compared with clinical gradients. Furthermore, a 1.6−2.1-fold increase in CNR was observed. Despite the more pronounced artefacts typically associated with strong\u003Cbr>This work is licensed under a BY 4.0 International license.\u003Cbr>Correspondence to: Malwina Molendowska.\u003Cbr>Correspondence Malwina Molendowska, School of Psychology, Cardiff University Brain Research Imaging, Centre (CUBRIC), Cardiff University, Maindy Road, CF24 4HQ Wales, UK , molendowskam@cardiff ac uk |\n\nEurope PMC unders uthManuscripts Europe M eC und Author Manuscripts  \nMolendowska et al. Page 2  \ngradients, a satisfactory correction could be achieved. Smoother and less biased parameter maps were obtained with protocols at shorter TEs. The results of this study show that dMRI in PCa with a whole-body 300-mT/m scanner is feasible without a report of physiological effects, SNR and CNR can be improved compared with lower gradient strengths, and artefacts do not negate the benefits of strong gradients and can be ameliorated. This assessment provides the first essential step towards unveiling the full potential of cutting-edge scanners, now increasingly becoming available, to advance early detection and diagnostic precision.  \nKeywords  \ndiagnostic imaging; diffusion MRI; high b-values; prostate cancer; strong gradients  \nAbbreviations ADC  \nAP  \nAS  \nCNR  \ndMRI  \nEPI  \n","cbCaiow5uM7R4m1q","https://ap.wps.com/l/cbCaiow5uM7R4m1q","pdf",2600946,24,"English","# Abstract\n# Keywords\n## Abbreviations\n# 1 Introduction","[{\"question\":\"Why is diffusion-weighted MRI challenging in clinical prostate cancer imaging?\",\"answer\":\"Clinical dMRI often has low signal-to-noise ratio due to prolonged echo times caused by limited gradient power, which increases signal loss from transverse relaxation.\"},{\"question\":\"What was the goal of using a 300 mT/m whole-body diffusion MRI system?\",\"answer\":\"The study aimed to assess feasibility and improve data quality, SNR, and contrast-to-noise ratio for prostate cancer measurements using ultra-strong gradients.\"},{\"question\":\"How did strong gradients affect image quality and contrast in the study?\",\"answer\":\"Strong gradients enabled a significant SNR gain per unit time and a 1.6–2.1-fold increase in contrast-to-noise ratio, while artefact correction supported acceptable diagnostic outcomes.\"}]","Diffusion MRI in prostate cancer with ultra-strong whole-body gradients - read online free | PDF",1790012446,[146,150,154],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/efbd9def518c93945419b68d58884a28.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/64c7cd9ac3d6c18525f07b6ac6f75233.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/87cf5d730c7853a57989727ec2272d6b.webp",981,1269]